Development and validation of a patient reported outcome measure for giant cell arteritis
(2021)
Presentation / Conference Contribution
All Outputs (9)
E038 A common measure of the impact of glucocorticoids in patients with inflammatory and autoimmune conditions - The Steroid PRO: A cross-cultural validation study with Rasch models
Presentation / Conference Contribution
Background/Aims Systemic glucocorticoids are key in the management of life- and organ-threatening rheumatic diseases, but have wide-ranging adverse effects of concern to patients and clinicians. We aimed to validate a Patient Reported Outcome (PRO) m... Read More about E038 A common measure of the impact of glucocorticoids in patients with inflammatory and autoimmune conditions - The Steroid PRO: A cross-cultural validation study with Rasch models.
P301 Patient reported outcome measure for giant cell arteritis: Clinical testing
Presentation / Conference Contribution
Background/Aims
Giant cell arteritis (GCA) presents in people over 50, with headaches, visual involvement and large vessel vasculitis. A 30-item GCA-specific patient reported outcome measure (GCA PRO) was developed and tested in a clinical setting t... Read More about P301 Patient reported outcome measure for giant cell arteritis: Clinical testing.
OA23 Patient-reported outcome measure for giant cell arteritis: Cross-sectional validation study
Presentation / Conference Contribution
CO7 Patient reported outcome measure for giant cell arteritis: cross-sectional validation study
Presentation / Conference Contribution
P041 Health-related quality of life in patients receiving glucocorticoids for a rheumatic disease and associated factors: A cross-sectional study
Presentation / Conference Contribution
Background/Aims Glucocorticoids (GCs) used in the treatment of inflammatory rheumatic conditions can impact on patients in different ways. The objective of this study was to identify socio-demographic and clinical factors associated with health-relat... Read More about P041 Health-related quality of life in patients receiving glucocorticoids for a rheumatic disease and associated factors: A cross-sectional study.
P186 Impact of glucocorticoids on appearance and sense of self in rheumatic diseases
Presentation / Conference Contribution